BD AutoShield™ Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes
The only pen needle with patented dual needle shields for enhanced convenience and safety is latest BD innovation for insulin injection
Franklin Lakes, NJ (August 06, 2014) –
BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the retail pharmacy launch of BD AutoShield™ Duo, the only pen needle with patented dual front and back-end shields that provides greater convenience and safety before and after injecting. The technology conceals the needle, helping to alleviate pre-injection anxiety while helping to reduce the risk of accidental needle stick for patients who inject insulin or other diabetes drugs.
The BD AutoShield Duo pen needle is easier to use because there is no inner needle shield to manage and no re-capping necessary, allowing people to dispose of the pen needle in a sharps container when it’s convenient to help avoid risk of an accidental needle stick. A front shield automatically covers the needle before and after an injection, and a second shield passively covers the back end needle after injection. Additionally, the front shield helps conceal the needle to reduce injection-related anxiety. Many prescribers and pharmacists have reported that a less visible needle may reduce stress and other potential psychological barriers associated with injection for some patients.
Availability should mean that you can purchase these needles at most pharmacies and that insurance coverage should generally be available although co-pays and preferred status may vary.
To read more see the press release.